Ultralife Corp. buy Benchmark Co.
Start price
15.11.24
/
50%
€7.30
Target price
15.11.25
€13.29
Performance (%)
-19.18%
Price
02.10.25
€5.70
Summary
This prediction is currently active. The prediction for Ultralife Corp. disappoints with a performance of -19.18%. This prediction currently runs until 15.11.25. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultralife Corp. | 1.786% | 1.786% |
| iShares Core DAX® | 2.709% | 3.467% |
| iShares Nasdaq 100 | 0.867% | 5.198% |
| iShares Nikkei 225® | 3.135% | 9.423% |
| iShares S&P 500 | 0.886% | 3.586% |
Comments by Benchmark_Co_ for this prediction
In the thread Ultralife Corp. diskutieren
Ultralife Co. (NASDAQ: ULBI) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $14.00 price target on the stock.
Ratings data for ULBI provided by MarketBeat